Biological Correlates of Acute Hypersensitivity Events with DAB389IL-2 (Denileukin Diftitox, ONTAK®) in Cutaneous T-Cell Lymphoma: Decreased Frequency and Severity with Steroid Premedication

This publication has 12 references indexed in Scilit:

• Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
  Journal of Clinical Oncology, 2001
• Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides
  Journal of the American Academy of Dermatology, 1998
• Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells
  Protein Engineering, Design and Selection, 1991
• Interleukin 2 receptor‐targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin‐related interleukin 2 fusion protein into cells
  European Journal of Immunology, 1990
• A possible role for Na+,K+-ATPase in regulating ATP-dependent endosome acidification.
  Proceedings of the National Academy of Sciences, 1989
• Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
  The Journal of Experimental Medicine, 1988
• Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein
  Protein Engineering, Design and Selection, 1987
• Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin.
  The Journal of cell biology, 1985
• Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes.
  Proceedings of the National Academy of Sciences, 1981
• Diphtheria toxin forms transmembrane channels in planar lipid bilayers.
  Proceedings of the National Academy of Sciences, 1981